No products in the cart.
Hicoly 2Million IU Injection
- Brand: Intas Pharmaceuticals Ltd
$62.62$69.57
In stock
Brand Name: Hicoly 2Million IU Injection
Composition: Colistin (2Million IU)
Manufactured By: Intas Pharmaceuticals Ltd
Form: vial
Packing: 1 Injection in 1 vial
Hicoly 2Million IU Injection Description:
Hicoly 2Million IU Injection is an antibiotic. It kills bacteria by destroying the bacterial cell membrane.
Uses:
Hicoly 2Million IU Injection is used in the treatment of bacterial infections and serious bacterial infections.
Side Effects:
Nausea, Nephrotoxicity, Neurotoxicity, Peripheral neuropathy (tingling and numbness of feet and hand), Acute tubular necrosis, Confusion, Dizziness, Muscle weakness, Renal injury, Respiratory distress, Secondary infections, Visual impairment, Vomiting.
Dosage:
Your doctor or nurse will give you this medicine. Kindly do not self administer.
FAQs
Is Hicoly an antibiotic / a bactericidal?
Yes Hicoly is an antibiotic with bactericidal action
Is Hicoly broad spectrum antibiotic?
No, Hicoly belongs to a class of drugs called polymyxin antibiotic
Does Hicoly cover pseudomonas?
Yes, Hicoly is effective against pseudomonas.
Buy Hicoly 2Million IU Injection online at discounted prices
If you are looking to buy Hicoly 2Million IU Injection, your search ends at Medslane. Medslane is one of the leading online medicine exporters & suppliers of generic and branded drugs. The company will offer you authentic medicines at best prices, and will also help you save a lot of money.
Check Hicoly 2Million IU Injection price in India, compare it with our online pharmacy and place your order online as soon as possible. As a healthcare brand, we will offer an on-time delivery of your medicines at your doorsteps. Australia, China, Russia, USA, UK, UAE, Vietnam, Cambodia, Philippines, Japan, Peru, Pakistan, Singapore, Malaysia, South Africa and South Korea are few of those countries we deliver to.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.